PhotonPharma

PhotonPharma is developing the Innocell therapeutic cancer vaccine, designed for personalized treatment using autologous tumor tissue. The technology is based on a photochemical inactivation platform, designed to use riboflavin (vitamin B2) and ultraviolet light in a proprietary method to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms.